Drugs / HIV gag-pol antigens
last change Sep 2003 re-read 2 minutes ago

HIV gag-pol antigens

Developed for
HIV infectious disease
Investigated by
Kirby Institute · The University of New South Wales · Virax Pty. Ltd,

Trials 1 · a red edge is where a trial was stopped

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00332930 Sep 2002 → Sep 2003 HIV infectious disease Kirby Institute Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HIV gag-pol antigens ClinicalTrials.gov intervention name — accepted as the source's own label NCT00332930
Route Intramuscular “Vaccines will be delivered by intramuscular injection.” NCT00332930